Pharmaceutical industry in Puerto Rico

Economy of Puerto Rico
Part of a series on the
Economic history of Puerto Rico
Currencies
Primary sectors
Agriculture Electricity Energy Fishing
Secondary sectors
Aerospace Automotives Construction Electronics Food service Pharmaceutics Petrochemicals PRIDCO Research Technology Textiles
Tertiary sectors
Banking Cooperativism Education Finance Healthcare Hotel Insurance Money transfers Mortgage Private security Public utilities Recreation Real estate Retail Social programs Telecommunications Tourism Transportation Warehousing Wholesale
Entertainment
Arts Filming Music News media Television
Companies
Companies of Puerto Rico Government-owned corporations Public-private partnerships
Government
Agencies Department of Economic Development and Commerce Department of Treasury Economic Development Bank Government-owned corporations Planning Board Office of Management and Budget Public-Private Partnerships Authority
Assets Consolidated Fund General Fund Public Improvements Fund Special State Funds
Bond issuers AFI AFICA Authority for the Financing of the Infrastructure of Puerto Rico COFINA Government Development Bank Municipal Financing Agency
Public debt Balance Budget Bonds issued by Puerto Rico Debt crisis Public debt of Puerto Rico
Taxes Internal Revenue Code Sales and Use Tax Taxation in Puerto Rico
Trade associations Chamber of Commerce Chamber of Marketing, Industry, and Distribution of Food Made in Puerto Rico MIDA Manufacturers Association Puerto Rico Products Association United Retailers Center

The pharmaceutical industry in Puerto Rico encompasses more than half of all manufacturing done in Puerto Rico. As the island's most prominent industry, pharmaceutics generates more than 18,000 jobs, pays more than $3 billion USD in taxes, comprises about half of total exports, and has generated more than 25% of the island's GDP for the past four decades.^[1] Comparatively, Puerto Rico is the fifth largest area in the world for pharmaceutical manufacturing with more than 80 plants, including:

Pharmaceutical companies originally came to Puerto Rico in the late 1960s and 1970s to take advantage of the now-expired federal tax incentive known as Section 936. This incentive allowed U.S.-based manufacturers to send all profits from local plants to stateside parent plants without having to pay any federal taxes.

Several developments in the market, however, pose a challenge to the industry. These challenges include expired patents, cheaper manufacturers (such as those in Brazil, China, India, and South Korea), the rise of generic drugs, and high production costs.^[1]

In terms of market share, as of 2014, Puerto Rico produces sixteen of the top twenty selling drugs in the mainland United States.^[2]

References

1 2 "La industria farmacéutica domina la manufactura en Puerto Rico – Microjuris - Puerto Rico". Aldia.microjuris.com. Retrieved 2015-03-01.
↑ Casiano Communications. "Caribbean Business". caribbeanbusinesspr.com. Retrieved 17 April 2014.

This article is issued from Wikipedia - version of the 8/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.